AXDX | Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Expected to Post Quarterly Sales of $4.44 Million

Wall Street brokerages expect that Accelerate Diagnostics, Inc.(NASDAQ:AXDX) will announce sales of $4.44 million for the current quarter, Zacks Investment Research reports.Three analysts have provided estimates for Accelerate Diagnostics’ earnings.The lowest sales estimate is $3.79 million and the highest is $5.53 million.Accelerate Diagnostics posted sales of $3.50 million during the same […]Transcript Daily

AXDX | Accelerate Diagnostics (NASDAQ:AXDX) Price Target Lowered to $15.00 at Piper Sandler

Accelerate Diagnostics (NASDAQ:AXDX) had its price objective reduced by Piper Sandler from $18.00 to $15.00 in a research note published on Friday morning, The Fly reports.Piper Sandler currently has an overweight rating on the medical research company’s stock.Several other research firms have also recently weighed in on AXDX.Zacks Investment Research cut Accelerate […]The Olympia Report